Back to PollNow

Back to companies

Alzamend Neuro, Inc.

ALZNUSNASDAQPharmaceuticals & Healthcare

Alzamend Neuro, Inc.

Revenue

—

FY2026

Operating income

-$8.8mn

FY2026

Employees

—

Founded

—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API